Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
Molecular Therapy. Nucleic Acids|October 16, 2023
CRISPR-Cas9 delivery strategies with engineered extracellular vesiclesYaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.Cells|February 25, 2023
Prime Editing for Human Gene Therapy: Where Are We Now?Kelly Godbout, Jacques P TremblayPharmaceutics|October 27, 2022
Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene TherapyKelly Godbout, Jacques P TremblayMedecine Sciences : M/S|October 25, 2024
[Correcting pathogenic mutations using prime editing: an overview]Camille Bouchard, Kelly Godbout, Jacques P TremblayCells|January 11, 2024
Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a MyopathyKelly Godbout, Joël Rousseau, Jacques P TremblayInternational Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.Frontiers in Medicine|April 14, 2022
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular DystrophyCedric Happi Mbakam, Gabriel Lamothe, Jacques P TremblayPlos One|December 28, 2020
The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cellsAntoine Guyon, Joël Rousseau, Gabriel Lamothe, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 15, 2022
CRISPR-Cas9 Gene Therapy for Duchenne Muscular DystrophyCedric Happi Mbakam, Gabriel Lamothe, Guillaume Tremblay, et al.Frontiers in Medicine|June 12, 2023
Prime editing strategies to mediate exon skipping in DMD geneCedric Happi Mbakam, Jeanne Roustant, Joel Rousseau, et al.Pageof 17